Color Atlas of Pharmacology

Description:

 

The Fifth Edition of Luellmann's Color Atlas of Pharmacology has been extensively revised to include all recent advances and new drugs, and the illustrations have been optimized and updated. Each two-page spread presents concise text on the left complemented by detailed full-color illustrations on the right to help users quickly digest important facts and concepts.

Color-coded sections provide readers with a helpful framework with which to approach the latest developments in pharmacology.

Part 1, General Pharmacology, explains basic aspects, such as drug absorption, distribution, and elimination, along with the molecular mechanisms of drug actions

Part 2, Systems Pharmacology, presents the different groups of drugs, emphasizing their functional and therapeutic aspects

Part 3, Therapy of Selected Diseases, provides all the relevant information regarding the pharmacological treatment of a large number of conditions.

 

Key features:

 

User-friendly format ideal for study and review, self-assessment, and quick reference

Completely revised and updated, with 174 color plates

New glossary of important and interesting pharmacological terms

Updated detailed drug indexes containing current information on drugs listed by both generic and brand names

The Fifth Edition of Color Atlas of Pharmacology is an essential study guide and reference for every student, nurse, and practicing physician needing to keep up to date with recent advances in the field.

 

Table of Contents:

 

General Pharmacology

1 History of Pharmacology

1.1 History of Pharmacology

2 Drug Sources

2.1 Drug and Active Principle

2.2 Plants as Sources of Effective Medicines

2.3 Human Proteins as Medicines

2.4 Drug Development

2.5 Drug Benefit Assessment

2.6 Congeneric Drugs and Name Diversity

3 Drug Administration

3.1 Oral Dosage Forms

3.2 Drug Administration by Inhalation

3.3 Dermatological Agents

3.4 Distribution in the Body

4 Cellular Sites of Action

4.1 Targets of Drug Action

5 Distribution in the Body

5.1 External Barriers of the Body

5.2 Blood–Tissue Barriers

5.3 Membrane Permeation

5.4 Drug Transporters

5.5 Distribution of Drugs

5.6 Binding of Drugs to Plasma Proteins

6 Drug Elimination

6.1 The Liver as an Excretory Organ

6.2 Biotransformation of Drugs

6.3 Drug Metabolism by CYP

6.4 Enterohepatic Circulation

6.5 The Kidney as an Excretory Organ

6.6 Presystemic Elimination

7 Pharmacokinetics

7.1 Drug Concentration in the Body

7.2 Time Course of Drug Concentration

7.3 Time Course during Repeated Dosing

7.4 Accumulation

8 Quantification of Drug Action

8.1 Dose–Response Relationship

8.2 Concentration–Effect Relationship

8.3 Concentration–Binding Curves

9 Drug–Receptor Interaction

9.1 Types of Binding Forces

9.2 Agonists–Antagonists

9.3 Enantioselectivity of Drug Action

9.4 Receptor Types

9.5 G-Protein-coupled Receptors

9.6 Plasma Concentration and Effect

10 Adverse Drug Effects

10.1 Adverse Drug Effects: Causes

10.2 Drug Allergy

10.3 Cutaneous Reactions

10.4 Pregnancy and Lactation

10.5 Genetic Variation of Drug Effects

11 Drug-independent Effects

11.1 Placebo Therapy

Systems Pharmacology

12 Sympathetic Nervous System

12.1 Function of the Sympathetic System

12.2 Structure of the Sympathetic Nervous System

12.3 Adrenoceptor Subtypes and Catecholamine Actions

12.4 Sympathomimetics

12.5 Indirect Sympathomimetics

12.6 α-Sympathomimetics, α-Sympatholytics

12.7 β-Sympatholytics (β-blockers)

13 Parasympathetic Nervous System

13.1 Parasympathetic Functions

13.2 Cholinergic Synapse

13.3 Parasympathomimetics

13.4 Parasympatholytics

14 Biogenic Amines

14.1 Dopamine

14.2 Histamine

14.3 Serotonin

14.4 Substance P and Amino Acids

15 Vasodilators

15.1 Vasodilators—Overview

15.2 Organic Nitrates

15.3 Calcium Antagonists

16 Inhibitors of the Renin–Angiotensin–Aldosterone System

16.1 ACE Inhibitors

17 Drugs Acting on Smooth Muscle

17.1 Drugs Acting on Smooth Muscle

18 Cardiac Drugs

18.1 Cardiac Drugs—Overview

18.2 Cardiac Glycosides

18.3 Antiarrhythmic Drugs

19 Antianemic Agents

19.1 Treatment of Anemias

19.2 Iron Compounds

20 Antithrombotic Agents

20.1 Thrombosis Therapy

20.2 Vitamin K Antagonists and Vitamin K

20.3 Heparin

20.4 Fibrinolytics

20.5 Inhibitors of Platelet Aggregation

21 Plasma Volume Expanders

21.1 Plasma Volume Expanders

22 Drugs Used in Hyperlipoproteinemias

22.1 Lipid-lowering Agents

23 Diuretics

23.1 Diuretics—Overview

23.2 NaCl and Water Reabsorption in the Kidney

23.3 Diuretics of the Sulfonamide Type

23.4 Potassium-sparing Diuretics and Vasopressin

24 Water and Electrolyte Disorders

24.1 Water and Electrolyte Disorders

25 Gastrointestinal Tract

25.1 Treatment of Hyperacidity, Use of Laxatives

25.2 Antidiarrheal Agents

26 Drugs Affecting the Motor System

26.1 Motor System

26.2 Muscle Relaxants

27 Drugs for the Suppression of Pain (Analgesics)

27.1 Nociceptors and Pain Pathways

27.2 Eicosanoids

27.3 Antipyretic Analgesics

27.4 Local Anesthetics

27.5 Opioids

28 Drugs Acting on the Central Nervous System

28.1 General Anesthesia and General Anesthetic Drugs

28.2 Inhalational Anesthetics

28.3 Injectable Anesthetics

28.4 Anxiolytics

28.5 Pharmacokinetics of Benzodiazepines

28.6 Therapy of Depressive Illness

28.7 Therapy of Manic States

28.8 Therapy of Schizophrenia

29 Drugs Affecting the Endocrine System

29.1 Hypothalamic and Hypophyseal Hormones

29.2 Thyroid Hormone Therapy

29.3 Hyperthyroidism and Antithyroid Drugs

29.4 Glucocorticoid Therapy

29.5 Androgens, Anabolic Steroids, Antiandrogens

29.6 Follicular Growth and Ovulation

29.7 Oral Contraceptives

29.8 Antiestrogen and Antiprogestin Active Principles

29.9 Aromatase Inhibitors

29.10 Insulin Formulations

29.11 Treatment of Diabetes Mellitus

29.12 Type II Diabetes Mellitus

29.13 Oral Antidiabetic Drugs

29.14 Maintaining Calcium Homeostasis

30 Antibacterial Drugs

30.1 Drugs for Treating Bacterial Infections

30.2 Inhibitors of Cell Wall Synthesis

30.3 Pore Formers and Inhibitors of THF Synthesis

30.4 Inhibitors of DNA Function

30.5 Inhibitors of Protein Synthesis

30.6 Drugs for Treating Mycobacterial Infections

31 Antifungal Drugs

31.1 Drugs Used in the Treatment of Fungal Infections

32 Antiviral Drugs

32.1 Pharmacotherapy of Viral Infections

32.2 Drugs for the Treatment of HIV

33 Antiparasitic Drugs

33.1 Endo- and Ectoparasites

34 Tropical Diseases

34.1 Antimalarial Drugs

34.2 Other Tropical Diseases

35 Anticancer Drugs

35.1 Cytostatics

35.2 Interference with Cell Proliferation Signaling Pathways

35.3 Special Antineoplastic Drug Actions

36 Immune Modulators

36.1 Inhibition of Immune Responses

36.2 Calcineurin Inhibitors, Sirolimus

37 Antidotes

37.1 Antidotes and Treatment of Poisoning

38 “Recreational” Drugs

38.1 Psychotomimetics

38.2 Tobacco and Nicotine

38.3 Consequences of Tobacco Smoking

38.4 Alcohol Abuse

Therapy of Selected Diseases

39 Cardiovascular Diseases

39.1 Hypertension

39.2 Angina Pectoris

39.3 Antianginal Drugs

39.4 Acute Coronary syndrome—Myocardial Infarction

39.5 Congestive Heart Failure

39.6 Septic Shock

40 Neurological Diseases

40.1 Parkinson Disease

40.2 Epilepsy

40.3 Migraine

40.4 Emesis

40.5 Sleep Disorders

41 Eye Diseases

41.1 Glaucoma

42 Bone Disorders

42.1 Osteoporosis

43 Metabolic Disorders

43.1 Gout

43.2 Obesity

44 Immune Disorders

44.1 Atopy and Antiallergic Therapy

44.2 Bronchial Asthma

44.3 COPD

44.4 Rheumatoid Arthritis

44.5 Chronic Inflammatory Bowel Disease

44.6 Multiple Sclerosis

Further Reading

45 Further Reading

Glossary

46 Glossary

Drug Index

47 Drug Index

47.1 Antibodies

47.2 Kinase Inhibitors

47.3 Drug Names → Trade Names

47.4 Trade Names → Drug Names

Abbreviations

48 Abbreviations

Subject Index

 

An aparitie	2017
Autor	Heinz Luellmann,‎ Klaus Mohr,‎ Lutz Hein
Dimensiuni	12.7 x 1.9 x 18.4 cm
Editura	Thieme
Format	Paperback
ISBN	9783132410657
Limba	Engleza
Nr pag	416